64 related articles for article (PubMed ID: 17037375)
1. Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017).
Untch M; Huober J; Jackisch C; Schneeweiss A; Brucker SY; Dall P; Denkert C; Fasching PA; Fehm T; Gerber B; Janni W; Kühn T; Lüftner D; Möbus V; Müller V; Rody A; Sinn P; Thill M; Thomssen C; Harbeck N; Liedtke C
Geburtshilfe Frauenheilkd; 2017 Jun; 77(6):633-644. PubMed ID: 28769126
[TBL] [Abstract][Full Text] [Related]
2. Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019).
Untch M; Thomssen C; Bauerfeind I; Braun M; Brucker SY; Felberbaum R; Hagemann F; Haidinger R; Hönig A; Huober J; Jackisch C; Kolberg HC; Kolberg-Liedtke C; Kühn T; Lüftner D; Maass N; Reimer T; Schneeweiss A; Schumacher-Wulf E; Schütz F; Thill M; Wuerstlein R; Fasching PA; Harbeck N
Geburtshilfe Frauenheilkd; 2019 Jun; 79(6):591-604. PubMed ID: 31217628
[TBL] [Abstract][Full Text] [Related]
3. St. Gallen 2011: Summary of the Consensus Discussion.
Gnant M; Harbeck N; Thomssen C
Breast Care (Basel); 2011; 6(2):136-141. PubMed ID: 21633630
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant endocrine therapy in premenopausal women with breast cancer.
González Martín A; de la Cruz S; Márquez R
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():43-7. PubMed ID: 20711666
[No Abstract] [Full Text] [Related]
5. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility.
Franco JG; Oliveira JB; Petersen CG; Mauri AL; Baruffi R; Cavagna M
Med Hypotheses; 2012 Apr; 78(4):442-5. PubMed ID: 22284634
[TBL] [Abstract][Full Text] [Related]
7. [Postoperative adjuvant therapy for premenopausal patients with breast cancer].
Kurebayashi J
Nihon Rinsho; 2006 Oct; 64(10):1963-9. PubMed ID: 17037375
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy for premenopausal patients with early breast cancer.
Kurebayashi J
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):51-4. PubMed ID: 18197006
[TBL] [Abstract][Full Text] [Related]
9. The evolution of adjuvant endocrine therapy: developments since St Gallen 2005.
Smith IE; Arnedos M
Breast; 2007 Dec; 16 Suppl 2():S4-9. PubMed ID: 17764939
[TBL] [Abstract][Full Text] [Related]
10. Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives.
Del Mastro L; Levaggi A; Giraudi S; Pronzato P
Cancer Treat Rev; 2011 May; 37(3):208-11. PubMed ID: 20724078
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
